ALDH1A1 and neoplasm: After infiltrating in the cancer area, M2 subtypes increase the ratio of CD44+/CD166+ tumor cells and the expression of acetaldehyde dehydrogenase 1 (ALDH1), which is the marker of CSC (57, 67, 73).